Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2
US9585884B2 · kind B2 · utility
5Cited by
6References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 16, 2013 |
| Grant date | Mar 7, 2017 |
| Priority date | — |
| Expiry date | Dec 16, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to new pyrimidinone inhibitors of lipoprotein-associated phospholipase A2 activity, pharmaceutical compositions thereof, and methods of use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.